Treatment of Raynaud's phenomenon using botulinum toxin type B
AssigneeNational University Corporation Gunma University
InventorSei-ichiro Motegi
Life of this patent
Estimating the term…
Abstract
An effective amount of botulinum toxin type B is administered to a subject in need thereof for treating Raynaud's phenomenon. Botulinum toxin type B may be in a form of an injection, and may be locally administered to a disease affected site, in a dose of 200 to 400 units per disease affected site.
Claims2
A method of treating Raynaud's phenomenon, comprising administering a therapeutically effective amount of botulinum toxin type B to a subject in need thereof, wherein said botulinum toxin type B is injected to sites between fingers and at the external sides of metacarpophalangeal joints of the first and fifth fingers of the subject.
Dependencies are inferred from the claim text.